Great progress has been made over the past half-century, but TB remains a formidable global health problem, particularly in low- and middle-income countries. Understanding the mechanisms of pathogenesis and necessary and sufficient conditions for protection are critical. The need for inexpensive and sensitive point-of-care diagnostic tests for earlier detection of infection and disease, shorter and less-toxic drug regimens for drug-sensitive and -resistant TB, and a more effective vaccine than BCG is immense. New and better tools, greater support for international research, collaborations, and training will be required to dramatically reduce the burden of this devastating disease which still kills 1.6 million people annually.

More from our Archive

• DOI: 10.1002/art.42657 2023

  Safety and Efficacy of <scp>Long‐Term</scp> Voclosporin Treatment for Lupus Nephritis in the Phase 3 <scp>AURORA</scp> 2 Clinical Trial

  Amit Saxena, Ellen M. Ginzler, Keisha Gibson, Bancha Satirapoj, Adolfina Elizabeth Zuta Santillán, Olena Levchenko, Sandra Navarra, Tatsuya Atsumi, Shinsuke Yasuda, Nilmo Noel Chavez‐Perez, Cristina Arriens, Samir V. Parikh, Dawn J. Caster, Vanessa Birardi, Simrat Randhawa, Laura Lisk, Robert B. Huizinga, Y. K. Onno Teng

• DOI: 10.3390/vaccines11081304 2023

  Next-Generation TB Vaccines: Progress, Challenges, and Prospects

  Li Zhuang, Zhaoyang Ye, Linsheng Li, Ling Yang, Wenping Gong

• DOI: 10.3390/vaccines11081298 2023

  Pustular Eruption following COVID-19 Vaccination: A Narrative Case-Based Review

  Emmanouil Karampinis, Agoritsa Gravani, Polyxeni Gidarokosta, Dimitrios Petros Bogdanos, Angeliki-Viktoria Roussaki-Schulze, Efterpi Zafiriou

• DOI: 10.1182/blood.2023020209 2023

  Prevalence and significance of <i>DDX41</i> gene variants in the general population

  Sruthi Cheloor Kovilakam, Muxin Gu, William G. Dunn, Ludovica Marando, Clea Barcena, Serena Nik-Zainal, Irina Mohorianu, Siddhartha P. Kar, Margarete A. Fabre, Pedro M. Quiros, George S. Vassiliou

• DOI: 10.1126/sciimmunol.add1591 2023

  Clonally expanded CD38 ^hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor–associated arthritis

  Runci Wang, Anvita Singaraju, Kathryne E. Marks, Lorien Shakib, Garrett Dunlap, Ifeoluwakiisi Adejoorin, Stinne R. Greisen, Lin Chen, Aidan K. Tirpack, Carlos Aude, Miriam R. Fein, Derrick J. Todd, Lindsey MacFarlane, Susan M. Goodman, Edward F. DiCarlo, Elena M. Massarotti, Jeffrey A. Sparks, A. Helena Jonsson, Michael B. Brenner, Michael A. Postow, Karmela K. Chan, Anne R. Bass, Laura T. Donlin, Deepak A. Rao

• DOI: 10.1111/tan.15162 2023

  <i>HLA‐B*51:380</i>, a novel <scp>HLA‐B</scp> allele with one exonic mutation identified in a Greek individual

  Diamanto Kouniaki, Theofilos Athanassiades, Konstantinos Fotopoulos, Vasiliki Kitsiou, Alexandra Tsirogianni

• DOI: 10.3390/vaccines11081328 2023

  Tracing down the Updates on Dengue Virus—Molecular Biology, Antivirals, and Vaccine Strategies

  Shiza Malik, Omar Ahsan, Hassan Mumtaz, Muhammad Tahir Khan, Ranjit Sah, Yasir Waheed

• DOI: 10.1182/blood.2023020703 2023

  Mitigating inequity: ethically prioritizing patients for CAR T-cell therapy

  Jennifer A. H. Bell, Gregory A. Jeffries, Christine I. Chen

• DOI: 10.1111/tan.15161 2023

  The novel <scp><i>HLA‐A</i></scp><i>*30:01:24</i> allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual

  Can Lou, Yang He, Ke‐ming Du, Zhong‐zheng Zheng, Songsong Gong

• DOI: 10.1111/all.15825 2023

  Mechanisms of gut epithelial barrier impairment caused by food emulsifiers polysorbate 20 and polysorbate 80

  Ismail Ogulur, Duygu Yazici, Yagiz Pat, Elif Naz Bingöl, Huseyn Babayev, Sena Ardicli, Anja Heider, Beate Rückert, Vanitha Sampath, Raja Dhir, Mubeccel Akdis, Kari Nadeau, Cezmi A. Akdis